Stocks and Investing Stocks and Investing
Wed, April 7, 2021
[ 12:00 AM ] - WOPRAI
Joe Quatrochi Maintained (AMAT) at Buy with Increased Target to $160 on, Apr 7th, 2021
[ 12:00 AM ] - WOPRAI
Vijay Rakesh Maintained (AMAT) at Strong Buy with Increased Target to $155 on, Apr 7th, 2021
[ 12:00 AM ] - WOPRAI
Mehdi Hosseini Maintained (AMAT) at Buy and Held Target at $155 on, Apr 7th, 2021
[ 12:00 AM ] - WOPRAI
Bobby Griffin Downgraded (CASY) to Hold on, Apr 7th, 2021
[ 12:00 AM ] - WOPRAI
Christopher Harris Maintained (BLK) at Buy with Increased Target to $890 on, Apr 7th, 2021
[ 12:00 AM ] - WOPRAI
Michael Rehaut Maintained (BLD) at Sell with Increased Target to $215 on, Apr 7th, 2021
[ 12:00 AM ] - WOPRAI
Richard Hill Maintained (SPG) at Buy with Increased Target to $135 on, Apr 7th, 2021
[ 12:00 AM ] - WOPRAI
David Long Maintained (SNV) at Buy with Increased Target to $53 on, Apr 7th, 2021
[ 12:00 AM ] - WOPRAI
David Long Maintained (VBTX) at Strong Buy with Increased Target to $40 on, Apr 7th, 2021
[ 12:00 AM ] - WOPRAI
Stan Zlotsky Downgraded (VERX) to Sell and Held Target at $18 on, Apr 7th, 2021
[ 12:00 AM ] - WOPRAI
Jason Goldberg Maintained (USB) at Buy with Increased Target to $65 on, Apr 7th, 2021
[ 12:00 AM ] - WOPRAI
Steven Forbes Maintained (TSCO) at Strong Buy with Increased Target to $200 on, Apr 7th, 2021
[ 12:00 AM ] - WOPRAI
Angie Storozynski Downgraded (CMS) to Hold on, Apr 7th, 2021
Tue, April 6, 2021
[ 12:00 AM ] - WOPRAI
Kaumil Gajrawala Initiated (CELH) at Hold and Held Target at $17 on, Apr 6th, 2021
[ 12:00 AM ] - WOPRAI
Mark Mahaney Initiated (TRUP) at Buy and Held Target at $100 on, Apr 6th, 2021
[ 12:00 AM ] - WOPRAI
Kaumil Gajrawala Initiated (SMPL) at Hold and Held Target at $31 on, Apr 6th, 2021
[ 12:00 AM ] - WOPRAI
Ravi Shanker Maintained (SNDR) at Buy with Increased Target to $30 on, Apr 6th, 2021
[ 12:00 AM ] - WOPRAI
James Cordwell Upgraded (SNAP) to Buy and Held Target at $75 on, Apr 6th, 2021
[ 12:00 AM ] - WOPRAI
Mark Mahaney Initiated (BMBL) at Hold and Held Target at $64 on, Apr 6th, 2021
[ 12:00 AM ] - WOPRAI
Julian Mitchell Upgraded (ALLE) to Buy and Increased Target to $150 on, Apr 6th, 2021
[ 12:00 AM ] - WOPRAI
Sterling Auty Initiated (ALRM) at Hold and Held Target at $100 on, Apr 6th, 2021
[ 12:00 AM ] - WOPRAI
Colin Bristow Initiated (ALXO) at Strong Buy and Held Target at $96 on, Apr 6th, 2021
[ 12:00 AM ] - WOPRAI
Bryan Keane Maintained (ACN) at Strong Buy with Increased Target to $310 on, Apr 6th, 2021
[ 12:00 AM ] - WOPRAI
Robert Lee Downgraded (AB) to Hold and Held Target at $42 on, Apr 6th, 2021
[ 12:00 AM ] - WOPRAI
Katy Huberty Maintained (AAPL) at Buy with Decreased Target to $156 on, Apr 6th, 2021
[ 12:00 AM ] - WOPRAI
Mark Mahaney Initiated (ABNB) at Buy and Held Target at $245 on, Apr 6th, 2021
[ 12:00 AM ] - WOPRAI
Salveen Richter Downgraded (ACAD) to Hold and Decreased Target to $25 on, Apr 6th, 2021
[ 12:00 AM ] - WOPRAI
Chris Howerton Downgraded (ACAD) to Hold and Decreased Target to $21 on, Apr 6th, 2021
[ 12:00 AM ] - WOPRAI
Vamil Divan Downgraded (ACAD) to Hold and Held Target at $25 on, Apr 6th, 2021
[ 12:00 AM ] - WOPRAI
Sumant Kulkarni Downgraded (ACAD) to Hold and Decreased Target to $26 on, Apr 6th, 2021

Sumant Kulkarni Downgraded (ACAD) to Hold and Decreased Target to $26 on, Apr 6th, 2021


Published on 2024-10-27 16:07:48 - WOPRAI, Sumant Kulkarni
  Print publication without navigation


Sumant Kulkarni of Canaccord Genuity, Downgraded "ACADIA Pharmaceuticals Inc." (ACAD) to Hold and Decreased Target from $40 to $26 on, Apr 6th, 2021.

Sumant has made no other calls on ACAD in the last 4 months.



There are 7 other peers that have a rating on ACAD. Out of the 7 peers that are also analyzing ACAD, 4 agree with Sumant's Rating of Hold. Following are those relevant analyst calls for the last 4 months

  • Tazeen Ahmad of "B of A Securities" Downgraded from Strong Buy to Hold on, Wednesday, March 10th, 2021
  • Yatin Suneja of "Guggenheim" Downgraded from Strong Buy to Hold on, Tuesday, March 9th, 2021
  • Neena Bitritto-Garg of "Citigroup" Downgraded from Strong Buy to Hold and Decreased Target to $35 on, Tuesday, March 9th, 2021
  • Paul Matteis of "Stifel" Downgraded from Strong Buy to Hold and Decreased Target to $27 on, Tuesday, March 9th, 2021


These are the ratings of the 3 analyists that currently disagree with Sumant

  • Joseph Stringer of "Needham" Maintained at Strong Buy with Decreased Target to $30 on, Monday, April 5th, 2021
  • Andrew Fein of "HC Wainwright & Co." Maintained at Strong Buy with Decreased Target to $43 on, Tuesday, March 9th, 2021
  • Danielle Brill of "Raymond James" Downgraded from Strong Buy to Buy and Decreased Target to $35 on, Tuesday, March 9th, 2021
Contributing Sources